Blog

Kiran Kehoe, RN, BSN, CCRN is a member of the KCA’s Clinical Advisory Board and sees patients at Memorial Sloan Kettering Cancer Center in New York. We spoke about her work supporting kidney cancer patients. Kiran Kehoe (right) with Dr. Ritesh Kotecha and Dr. Chung-Han Lee met with a New York state representative during the KCA’s Advocacy Days in Washington…

Welcome to our new series where we take a look at what's happening in kidney cancer each month! From treatments and clinical trials to genetic testing and government regulations, the KCA's Medical Director, Sallie McAdoo, MS, CGC, will show you what's new and why it matters. This month, there were two major announcements about kidney cancer treatments. Cabometyx plus Opdivo…

The Kidney Cancer Association, alongside the American Urological Association and a group of kidney cancer-focused advocacy organizations, wrote this week to congratulate then-President-elect Joe Biden and urge him to make the needs of people impacted by kidney cancer and kidney cancer research a top priority for the incoming administration. President Biden has a deep understanding of both the personal devastation…

Nina Decker, MSW, LCSW, is a member of the KCA’s Clinical Advisory Board and sees patients at the Cedars-Sinai Medical Center in Los Angeles, California. We spoke about her work supporting kidney cancer patients. How long have you been working with the KCA and what motivated you to get involved? I have only been with the KCA since late summer…

Kayla's daughter Jane was born in June 2020, just a month before Kayla received a kidney cancer diagnosis. In June 2020, Kayla Bulkley gave birth to her and her husband's long-awaited baby girl, Jane.  Within a month, Kayla was diagnosed with kidney cancer.  "It was a Saturday and we were getting newborn photos done with Jane and I felt TERRIBLE,"…

Meghara Walsh, RN, BSN, is a member of the KCA’s Clinical Advisory Board and works at Dana-Farber Cancer Institute in Boston, Massachusetts. We spoke about her work with the KCA and in oncology nursing. How long have you been working with the KCA and what motivated you to get involved? I am still new to the Kidney Cancer Association as…

As the 30th anniversary of the Kidney Cancer Association comes to a close, we are taking stock of some of the milestones and initiatives this community has been a part of. Since it was founded in 1990, the KCA and the kidney cancer community have seen kidney cancer evolve from a disease with few treatment options and a limited future…

We began 2020 with high hopes of achieving more for the kidney cancer community than ever before. Through a pandemic that continues to impact people across the world, we remained committed to bringing our mission to people affected by kidney cancer through resources and services that empower them to live better with kidney cancer. Here are a few of the…

Dr. Brian Rini is the inaugural Chief of Clinical Trials at Vanderbilt-Ingram Cancer Center (VICC) in Nashville, Tennessee and a member of the KCA's Medical Steering Committee, which provides strategic guidance to the KCA on medical and patient education programs. We spoke with Dr. Rini about his work with the KCA and with patients. Dr. Brian Rini (right) with Dr. Bradley Leibovich,…

Dr. Tian Zhang is a medical oncologist at the Duke Cancer Institute. She is a 2019 KCA Young Investigator Award recipient and has contributed to the “Ask the Experts” resource about COVID-19 and kidney cancer. UPDATED information about Moderna's COVID-19 vaccine below. https://www.kidneycancer.org/covid-19-information-and-resources/ Nearly 10 months after the COVID-19 pandemic became a major public health threat, hopes for a vaccine…